| Financial Year |
March 31 2023 |
| Monetary Funds |
9,264,579,292.00 |
| Held-for-trading Financial Assets |
3,695,815,818.78 |
| Notes Receivable |
1,109,506,720.96 |
| Accounts Receivable |
9,207,710,486.73 |
| Advances to Suppliers |
1,921,253,162.81 |
| Other Receivables |
458,965,960.30 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
7,860,102,229.66 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
979,056,804.14 |
| Total Current Assets |
36,574,672,892.06 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
11,986,276,457.35 |
| Investment Properties |
-- |
| Fixed Assetes |
12,024,212,863.34 |
| Under-construction Projects |
17,252,771,231.02 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,298,717,365.17 |
| R&D expenses |
125,283,125.80 |
| Goodwill |
65,798,821.25 |
| Long-Term Deferred and Prepaid Expenses |
405,589,330.41 |
| Deferred Income Tax Assets |
891,374,979.91 |
| Other Non-Current Assets |
3,720,930,518.49 |
| Sub-Total of Non-Current Assets |
49,772,653,874.60 |
| Total Assets |
86,347,326,766.66 |
| Short-Term Loans |
1,637,549,719.37 |
| Trading Financial liabilities |
530,000.00 |
| Notes Payable |
8,813,883,095.43 |
| Accounts Payable |
16,881,097,381.43 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
268,675,513.50 |
| Taxes Payable |
118,799,411.42 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
79,485,074.19 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,264,926,290.99 |
| Other Current Liabilities |
751,567,870.52 |
| Sub-Total of Current Liabilities |
32,727,391,413.83 |
| Long-term Loans |
14,420,173,584.38 |
| Bonds Payable |
2,382,388,462.37 |
| Long-Term Accounts Payable |
725,992,329.01 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
457,278,752.46 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
18,801,354,201.85 |
| Total Liabilities |
51,528,745,615.68 |
| Paid-In Capital(Or Share Stock) |
2,045,721,497.00 |
| Capital Surplus |
18,187,060,864.43 |
| Surplus Reserve |
430,122,108.28 |
| LESS:Treasury Stock |
249,890,029.54 |
| Undistributed Profits |
11,584,693,125.37 |
| Minority Stockholder's Interest |
2,953,635,922.29 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
31,864,945,228.69 |
| Owner's Equity（Stockholder's Equity） |
34,818,581,150.98 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
86,347,326,766.66 |
